Challenges and advances of immune checkpoint therapy
Abstract Background and Objectives Immuno‐checkpoint therapy (ICT) significantly alters the clinical course of cancer patients, providing long‐lasting clinical benefits and offering the potential for cure to some patients. However, response rates for different tumour types vary, and predictive bioma...
Saved in:
| Main Authors: | Lingyu Li, Yingli Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Clinical and Translational Discovery |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ctd2.70001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade
by: Yan Zhang, et al.
Published: (2019-08-01) -
Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications
by: Erfan Rezazadeh‐Gavgani, et al.
Published: (2025-04-01) -
The neurotoxic effects of immune checkpoint inhibitor therapy for melanoma
by: Lavinia Spain, et al.
Published: (2019-06-01) -
Immune checkpoint inhibition perturbs neuro-immune homeostasis and impairs cognitive function
by: Onwodi V. Ifejeokwu, et al.
Published: (2025-07-01) -
Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report
by: Marco Juul Thomsen, et al.
Published: (2025-07-01)